Ballew Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Ballew Advisors's JNJ Position: Q2 2026 in Review
Ballew Advisors increased its Johnson & Johnson (JNJ) stake by 0.05% in Q2 2026, buying an estimated $233 and bringing the position to 1,837 shares worth $483K. The position accounts for 0.25% of the portfolio, ranked #76.
Ballew Advisors first reported a position in JNJ in Q4 2017 and has held it in 22 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ballew Advisors held 1,837 shares of Johnson & Johnson worth $483K as of Q2 2026.
- Ballew Advisors bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
- Johnson & Johnson made up 0.25% of Ballew Advisors's portfolio in Q2 2026, its #76 holding.
- Ballew Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 22 quarters since.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ballew Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.